Search research articles
Contact Us
Filters
Showing results (1-10 of 15) with videos related to
Page
of 2
Sort By:
Journal of Biomolecular Screening
|
February 4, 2014
Fluorescence Lifetime-Based Competitive Binding Assays for Measuring the Binding Potency of Protease Inhibitors In Vitro
Andreas Boettcher, Nathalie Gradoux, Edwige Lorthiois, et al.
The EMBO Journal
|
March 24, 2019
Extrinsic and intrinsic apoptosis activate pannexin-1 to drive NLRP3 inflammasome assembly
Kaiwen W Chen, Benjamin Demarco, Rosalie Heilig, et al.
Journal of Biomolecular Screening
|
June 9, 2006
Readout technologies for highly miniaturized kinase assays applicable to high-throughput screening in a 1536-well format
Martin Klumpp, Andreas Boettcher, Damaris Becker, et al.
Journal of Biomolecular Screening
|
September 22, 2010
Fragment-based screening by biochemical assays: Systematic feasibility studies with trypsin and MMP12
Andreas Boettcher, Simon Ruedisser, Paulus Erbel, et al.
Plos One
|
February 15, 2013
In vivo imaging with fluorescent smart probes to assess treatment strategies for acute pancreatitis
Abhiruchi Agarwal, Andreas Boettcher, Rainer Kneuer, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
September 4, 2009
Knowledge-based virtual screening: application to the MDM4/p53 protein-protein interaction
Edgar Jacoby, Andreas Boettcher, Lorenz M Mayr, et al.
Biochemical and Biophysical Research Communications
|
February 9, 2021
Pharmacological inhibition of IKKβ dampens NLRP3 inflammasome activation after priming in the human myeloid cell line THP-1
Adeline Unterreiner, Joëlle Rubert, Muriel Kauffmann, et al.
Journal of Molecular Biology
|
October 23, 2021
Crystal Structure of NLRP3 NACHT Domain With an Inhibitor Defines Mechanism of Inflammasome Inhibition
Carien Dekker, Henri Mattes, Michael Wright, et al.
Journal of Medicinal Chemistry
|
January 4, 2024
Discovery of Potent, Orally Bioavailable, Tricyclic NLRP3 Inhibitors
Juraj Velcicky, Philipp Janser, Nina Gommermann, et al.
Circulation
|
February 15, 2024
Clonal Hematopoiesis of Indeterminate Potential With Loss of <i>Tet2</i> Enhances Risk for Atrial Fibrillation Through <i>Nlrp3</i> Inflammasome Activation
Amy Erica Lin, Aneesh C Bapat, Ling Xiao, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 15) with videos related to
Sort By:
Page
of 2
Journal of Biomolecular Screening
|
February 4, 2014
Fluorescence Lifetime-Based Competitive Binding Assays for Measuring the Binding Potency of Protease Inhibitors In Vitro
Andreas Boettcher, Nathalie Gradoux, Edwige Lorthiois, et al.
The EMBO Journal
|
March 24, 2019
Extrinsic and intrinsic apoptosis activate pannexin-1 to drive NLRP3 inflammasome assembly
Kaiwen W Chen, Benjamin Demarco, Rosalie Heilig, et al.
Journal of Biomolecular Screening
|
June 9, 2006
Readout technologies for highly miniaturized kinase assays applicable to high-throughput screening in a 1536-well format
Martin Klumpp, Andreas Boettcher, Damaris Becker, et al.
Journal of Biomolecular Screening
|
September 22, 2010
Fragment-based screening by biochemical assays: Systematic feasibility studies with trypsin and MMP12
Andreas Boettcher, Simon Ruedisser, Paulus Erbel, et al.
Plos One
|
February 15, 2013
In vivo imaging with fluorescent smart probes to assess treatment strategies for acute pancreatitis
Abhiruchi Agarwal, Andreas Boettcher, Rainer Kneuer, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
September 4, 2009
Knowledge-based virtual screening: application to the MDM4/p53 protein-protein interaction
Edgar Jacoby, Andreas Boettcher, Lorenz M Mayr, et al.
Biochemical and Biophysical Research Communications
|
February 9, 2021
Pharmacological inhibition of IKKβ dampens NLRP3 inflammasome activation after priming in the human myeloid cell line THP-1
Adeline Unterreiner, Joëlle Rubert, Muriel Kauffmann, et al.
Journal of Molecular Biology
|
October 23, 2021
Crystal Structure of NLRP3 NACHT Domain With an Inhibitor Defines Mechanism of Inflammasome Inhibition
Carien Dekker, Henri Mattes, Michael Wright, et al.
Journal of Medicinal Chemistry
|
January 4, 2024
Discovery of Potent, Orally Bioavailable, Tricyclic NLRP3 Inhibitors
Juraj Velcicky, Philipp Janser, Nina Gommermann, et al.
Circulation
|
February 15, 2024
Clonal Hematopoiesis of Indeterminate Potential With Loss of <i>Tet2</i> Enhances Risk for Atrial Fibrillation Through <i>Nlrp3</i> Inflammasome Activation
Amy Erica Lin, Aneesh C Bapat, Ling Xiao, et al.
Page
of 2